CVE-2026-7251: Eppendorf BioFlo 320 Auth Bypass Vulnerability

CVE-2026-7251 Overview

CVE-2026-7251 affects the Eppendorf BioFlo 320 bioprocess control system. The device ships with a Virtual Network Computing (VNC) server that uses a hard-coded password [CWE-259]. A remote attacker who knows the network address of any BioFlo 320 with remote access enabled can authenticate using this static credential. Once connected, the attacker gains full control over the bioreactor user interface and all control panel functions. VNC traffic between the operator and the device is not encrypted, exposing session content to network observers.

Critical Impact

An unauthenticated remote attacker can take full control of a BioFlo 320 bioreactor over the network using a hard-coded VNC password, with no user interaction required.

Affected Products

• Eppendorf BioFlo 320 bioprocess control system with remote access enabled
• All firmware versions distributing the VNC server with the hard-coded password
• Refer to the Eppendorf Software Downloads page for current firmware availability

Discovery Timeline

• 2026-05-26 - CVE-2026-7251 published to the National Vulnerability Database (NVD)
• 2026-05-26 - CISA publishes ICS Medical Advisory ICSMA-26-146-01
• 2026-05-26 - Last updated in NVD database

Technical Details for CVE-2026-7251

Vulnerability Analysis

The BioFlo 320 exposes a VNC server to support remote operation of the device user interface. The server authenticates incoming sessions using a password that is embedded in the device firmware. The same credential is shared across all units in the field. Anyone who recovers the password from one device, the firmware image, or public disclosure can authenticate against every other unit reachable on the network.

VNC sessions also lack transport encryption. An attacker positioned on the network path can capture screen content, keystrokes, and control commands by passively recording traffic. The Common Weakness Enumeration assigns this issue to CWE-259: Use of Hard-coded Password.

Root Cause

The root cause is a design decision to embed a static authentication credential in the VNC service rather than provisioning per-device or user-managed credentials. Hard-coded credentials cannot be rotated by the operator and cannot be revoked when exposed. The absence of VNC transport encryption compounds the issue by leaking session data to any observer on the same network segment.

Attack Vector

Exploitation requires network reachability to the BioFlo 320 VNC port and knowledge of the hard-coded password. The attacker connects with any standard VNC client, authenticates, and interacts with the control panel as a local operator would. Once authenticated, the attacker can modify setpoints, start or stop processes, alter agitation and gas controls, and manipulate any parameter exposed through the touchscreen interface. Manipulation of a live bioprocess can damage cell cultures, batches, or downstream products.

No verified exploit code is available in public repositories at the time of writing. Technical details are described in the CISA Medical Advisory ICSMA-26-146-01 and the corresponding GitHub CSAF file.

Detection Methods for CVE-2026-7251

Indicators of Compromise

• Inbound TCP connections to VNC ports (typically 5900/TCP) on BioFlo 320 management interfaces from unexpected source addresses
• Successful VNC authentication events outside scheduled maintenance windows or from non-engineering workstations
• Unscheduled changes to bioreactor setpoints, recipes, or alarm thresholds that do not correlate with operator activity

Detection Strategies

• Inventory BioFlo 320 devices and identify any with VNC remote access enabled or exposed beyond the operations VLAN
• Inspect network flow data for VNC protocol traffic crossing segmentation boundaries between IT and OT networks
• Correlate device audit logs and process historian records to flag control changes that lack a matching operator login

Monitoring Recommendations

• Enable session logging on jump hosts used for remote BioFlo 320 access and forward logs to a central SIEM
• Alert on any VNC handshake to medical or laboratory device subnets from corporate or external ranges
• Periodically scan OT network segments for listening VNC services and confirm each is authorized

How to Mitigate CVE-2026-7251

Immediate Actions Required

• Disable the VNC remote access feature on BioFlo 320 units that do not require it
• Restrict network reachability of the BioFlo 320 management interface to a dedicated, firewalled OT segment
• Place any required remote access behind a hardened jump host with multi-factor authentication and session recording
• Contact Eppendorf support to obtain mitigation guidance and firmware updates as they become available

Patch Information

At the time of NVD publication, vendor remediation guidance is published through the CISA Medical Advisory ICSMA-26-146-01. Operators should monitor the Eppendorf Software Downloads portal for firmware updates that remove or replace the hard-coded VNC password and add transport encryption.

Workarounds

• Turn off the VNC server on every BioFlo 320 that does not have an operational requirement for remote access
• Apply strict allow-listing on firewalls so only specific engineering workstation IPs can reach the device VNC port
• Tunnel any required VNC sessions through an encrypted VPN or SSH tunnel to compensate for the lack of native encryption
• Physically isolate bioreactors processing critical batches from routable networks during sensitive runs

# Example host-based firewall rule restricting VNC to a single engineering workstation
# Replace 10.10.20.15 with the authorized workstation address and apply on the upstream firewall
iptables -A FORWARD -p tcp -s 10.10.20.15 -d <bioflo_ip> --dport 5900 -j ACCEPT
iptables -A FORWARD -p tcp -d <bioflo_ip> --dport 5900 -j DROP